Institutional Ownership Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 4.05 Million shares, which have been reported (via 13F filing form) to have a value of $6 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bml Capital Management, LLC
Zionsville, IN |
May 06, 2025 Q1 2025 |
3,804,921
shares
|
$5.63 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.2%
|
|
|
Xtx Topco LTD
London, X0 |
May 07, 2025 Q1 2025 |
38,923
shares
|
$57,606
0.0% of portfolio
|
Q1 2025
Added 45.11%
|
|
|
Brave Asset Management Inc
|
Apr 10, 2025 Q1 2025 |
10,000
shares
|
$14,800
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Apr 08, 2025 Q1 2025 |
4,480
shares
|
$6,630
0.0% of portfolio
|
Q2 2024
Added 27.49%
|
|
|
Endurance Wealth Management, Inc.
|
Aug 09, 2023 Q2 2023 |
2,000
shares
|
$2,960
0.0% of portfolio
|
Q1 2023
Added 99900.0%
|
|
|
Gamma Investing LLC
Foster City, CA |
Apr 07, 2025 Q1 2025 |
1,193
shares
|
$1,765
0.0% of portfolio
|
Q1 2025
Reduced 32.44%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
196
shares
|
$290
0.0% of portfolio
|
Q1 2025
Reduced 39.13%
|